Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® (CT-P42, aflibercept), a biosimilar to Eylea® to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback